Avivagen Inc. (CVE:VIV): See How It’s Revolutionizing the Livestock Industry

Avivagen seeing great results in eliminating antibiotics in favour of natural product

Avivagen Inc. (CVE:VIV) is seeing real benefits in enabling producers to raise animals without the use of antibiotics. At the RAI$E Conference in Toronto, SmallCapPower spoke with Cameron Groome, Avivagen’s CEO, about the Company’s OxC-Beta product, which replaces antibiotics in livestock feed, therefore enhancing overall animal health and immune functioning. He talks about VIV’s first industrial sale to a large feed producing company in the Philippines and a joint venture with a partner in China that will allow them quick access to the Chinese market.

For more exclusive coverage from the RAI$E Conference click here